2013
DOI: 10.4161/cc.25136
|View full text |Cite
|
Sign up to set email alerts
|

Inter-telomeric recombination is present in telomerase-positive human cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 58 publications
(72 reference statements)
0
3
0
Order By: Relevance
“…Organisms that have telomerase-generated telomeric DNA sequences also appear to have an alternative mechanism for lengthening telomeres (Royle et al 2009). For example, in yeast and human tumors, alternative process for the maintenance of telomeric sequences may occur readily even in the presence of telomerase (Teng and Zakian 1999;Cesare and Reddel 2010;Dlaska et al 2013). Thus, it is not surprising that over evolutionary time, telomerase-generated telomeric DNA sequences have been independently lost in Hymenoptera and other insect groups.…”
Section: Discussionmentioning
confidence: 99%
“…Organisms that have telomerase-generated telomeric DNA sequences also appear to have an alternative mechanism for lengthening telomeres (Royle et al 2009). For example, in yeast and human tumors, alternative process for the maintenance of telomeric sequences may occur readily even in the presence of telomerase (Teng and Zakian 1999;Cesare and Reddel 2010;Dlaska et al 2013). Thus, it is not surprising that over evolutionary time, telomerase-generated telomeric DNA sequences have been independently lost in Hymenoptera and other insect groups.…”
Section: Discussionmentioning
confidence: 99%
“…Given its wide distribution, telomerase obviously arose very early in the evolution of eukaryotes; it may also provide greater stringency or efficiency in the maintenance of the canonical sequence required by a sequence-specific capping complex than alternatives, such as recombination. These alternative mechanisms may occur readily, as seen in yeast (Teng and Zakian 1999) and human tumors (Cesare and Reddel 2010) even in the presence of telomerase (Dlaska et al 2013). In addition, short telomeres or loss of telomerase from human cancer cells may stimulate alternative lengthening of telomeres (ALT) mechanisms (Morrish and Greider 2009; Queisser et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…For example, it can be used as adjuvant to conventional cancer treatments, such as chemo-and radiotherapy, because it does not interfere with those treatment procedures and can add a new dimension to the therapy. We suggest that for the PdTMPyP4/PLGA implant to be a part of a comprehensive and potentially curative treatment strategy, it is equally important to address the ALT telomere-lengthening mechanism that is active regardless of whether telomerase is active or inhibited (Dlaska et al 2013;Jeyapalan et al 2005;Bechter et al 2004Bechter et al , 2004Henson et al 2002) and that predominates in certain cancer types (McDonald et al 2010). ALT activation and its elongation of telomeres presents an obstacle to the achievement of complete tumor remission.…”
Section: Discussionmentioning
confidence: 96%